Education
About Us
Working with TipRanks
Follow Us
AIVL - ETF AI Analysis
Top Page
WisdomTree U.S. AI Enhanced Value Fund (AIVL)
Rating:71Outperform
Price Target:―
Positive Factors
Strong Sector Diversification
The ETF is spread across multiple sectors, including financials, technology, and health care, reducing reliance on any single industry.
Solid Performance from Key Holdings
Several top holdings, such as Medtronic and Teledyne Technologies, have delivered strong year-to-date performance, contributing positively to the fund.
Reasonable Expense Ratio
The ETF charges a moderate expense ratio, which is competitive and helps investors retain more of their returns.
Negative Factors
High Geographic Concentration
The ETF is heavily focused on U.S. companies, offering limited exposure to international markets and diversification.
Underperforming Holdings
Some top holdings, such as Comcast and US Bancorp, have experienced weak year-to-date performance, which could drag on overall returns.
Moderate Asset Base
The fund's assets under management are relatively modest, which could limit liquidity and scalability compared to larger ETFs.
AIVL vs. SPDR S&P 500 ETF (SPY)
AUM381.04M
RegionNorth America
Expense Ratio0.38%
Beta0.63
IssuerWisdomTree
Inception DateJun 16, 2006
Dividend Yield1.68%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume2,500
30 Day Avg. Volume3,068
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
131.33Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering102
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
AIVL Summary
The WisdomTree U.S. AI Enhanced Value Fund (AIVL) is an ETF that uses artificial intelligence to find undervalued U.S. companies with strong growth potential. It focuses on value stocks across various sectors, including financials, technology, and healthcare. Some well-known companies in the fund include Bank of America and Exxon Mobil. Investors might consider AIVL for its unique approach to combining AI with value investing, offering a chance to diversify their portfolio with stocks that could be poised for appreciation. However, since it’s heavily focused on U.S. value stocks, its performance can fluctuate with market conditions and economic cycles.
How much will it cost me?The WisdomTree U.S. AI Enhanced Value Fund (AIVL) has an expense ratio of 0.38%, which means you’ll pay $3.80 per year for every $1,000 invested. This expense ratio is slightly higher than average for ETFs because it uses an actively managed, AI-enhanced strategy to identify value stocks, which requires more resources compared to passively managed funds. It may be worth the cost if you value its innovative approach to investing.
What would affect this ETF?The AIVL ETF, with its focus on U.S. value stocks and AI-driven strategy, could benefit from a strong U.S. economy, rising corporate earnings, and advancements in AI technology that enhance stock selection. However, it may face challenges from rising interest rates, which could pressure value stocks, or sector-specific risks in financials and technology, which are its largest exposures. Regulatory changes or economic slowdowns could also negatively impact its performance.
AIVL Top 10 Holdings
The WisdomTree U.S. AI Enhanced Value Fund (AIVL) leans heavily into financials and technology, with names like US Bancorp and Intercontinental Exchange shaping its trajectory. US Bancorp is steady but faces mixed signals, while Intercontinental Exchange is lagging due to bearish technical trends and challenges in its mortgage segment. On the brighter side, Exxon Mobil’s rising performance adds energy to the fund, and Medtronic’s steady growth provides a solid foundation. With its U.S.-focused portfolio and value-driven strategy, the fund’s sector concentration offers both opportunities and hurdles in navigating market shifts.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Medtronic | 3.35% | $12.78M | $134.64B | 21.73% | 74 Outperform | |
| US Bancorp | 3.30% | $12.60M | $76.09B | -8.47% | 75 Outperform | |
| Intercontinental Exchange | 3.21% | $12.27M | $89.11B | -3.04% | 71 Outperform | |
| RTX | 3.19% | $12.20M | $232.21B | 43.92% | 75 Outperform | |
| Boston Scientific | 3.14% | $11.98M | $149.67B | 11.25% | 79 Outperform | |
| Nisource | 3.11% | $11.90M | $20.88B | 14.40% | 67 Neutral | |
| Exxon Mobil | 2.96% | $11.32M | $484.00B | -2.46% | 75 Outperform | |
| Bank of America | 2.92% | $11.15M | $386.96B | 10.93% | 70 Outperform | |
| Fortive | 2.72% | $10.41M | $16.91B | -32.96% | 72 Outperform | |
| Nasdaq | 2.57% | $9.82M | $51.38B | 8.34% | 73 Outperform |
AIVL Technical Analysis
Positive
―
Price Trends
113.36
Positive
113.18
Positive
110.63
Positive
Market Momentum
-0.17
Negative
57.19
Neutral
76.72
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For AIVL, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 112.42, equal to the 50-day MA of 113.36, and equal to the 200-day MA of 110.63, indicating a bullish trend. The MACD of -0.17 indicates Negative momentum. The RSI at 57.19 is Neutral, neither overbought nor oversold. The STOCH value of 76.72 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AIVL.
AIVL Peer Comparison
Comparison Results
Performance Comparison
AIVL
WisdomTree U.S. AI Enhanced Value Fund
114.15
2.18
1.95%
VFVA
Vanguard U.S. Value Factor ETF
―
―
―
LSVD
LSV Disciplined Value ETF
―
―
―
QVAL
Alpha Architect U.S. Quantitative Value ETF
―
―
―
BUSA
Brandes U.S. Value ETF
―
―
―
GVLU
Gotham 1000 Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents